Merck is a leading science and technology company in the Healthcare, Life Science, and Performance Materials sectors. As of December 31, 2019, around 57,000 employees worldwide work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to display solutions, semiconductor solutions and surface solutions that advancing digital living. In 2019, Merck generated sales of € 16.2 billion in 66 countries.

Founded in 1668, Merck is the world’s oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group, one of the top 30 German companies traded in the Frankfurt Stock Exchange. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma, and EMD Performance Materials.

Merck has been in China for 87 years. In 1933, Merck founded E. Merck Chemical Co., Ltd., its first subsidiary in Shanghai.

China is one of the most strategically important countries for Merck and has become a global center of innovation for Merck. Merck’s Healthcare in Nantong, Life Science in Nantong and Performance Materials in Shanghai have investments of 170 million Euros, 80 million Euros, and 44 million Euros respectively. Additionally, Merck hosts a global Healthcare R&D hub in Beijing, Display Materials R&D Center, Life Science labs, APAC BioReliance® End-to-End Biodevelopment Center in Shanghai, as well as Display Patterning Materials R&D Center in Suzhou. Merck opened China Innovation Hub in Shanghai and Guangdong.

Every day, Merck’s 4,100 committed employees in China are delivering high-quality, innovative products in healthcare, life science and performance materials which have a significant impact on people’s lives.